All Publications

Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.

Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.

Liu C. et al, (2024), Nature communications, 15

The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.

Zhou D. et al, (2024), Nature communications, 15

Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.

Michael BD. et al, (2023), Nature communications, 14

Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera

Roper KJ. et al, (2023), Scientific Reports, 13

Structural comparison of typical and atypical E2 pestivirus glycoproteins.

Aitkenhead H. et al, (2023), Structure (London, England : 1993)

COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance.

Bou-Antoun S. et al, (2023), The Journal of antimicrobial chemotherapy, 78, ii37 - ii42

Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study.

Bešević J. et al, (2023), Journal of epidemiology and community health

Experimental phasing opportunities for macromolecular crystallography at very long wavelengths.

El Omari K. et al, (2023), Commun Chem, 6

ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface.

Ni T. et al, (2023), iScience, 26

Structure of Bovine CD46 Ectodomain

Aitkenhead H. et al, (2023), Viruses, 15, 1424 - 1424

Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy.

Ragonnet-Cronin M. et al, (2023), Nat Commun, 14

Accelerating drug target inhibitor discovery with a deep generative foundation model.

Chenthamarakshan V. et al, (2023), Science advances, 9

Broadly neutralizing antibodies against COVID-19.

Zhou D. et al, (2023), Current opinion in virology, 61

ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface

Zhang P. et al, (2023)

Cryogenic electron ptychographic single particle analysis with wide bandwidth information transfer.

Pei X. et al, (2023), Nature communications, 14

Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK.

Wei J. et al, (2023), Nature communications, 14

Isolation of a pair of potent broadly neutralizing mAb binding to RBD and SD1 domains of SARS-CoV-2

Stuart D. et al, (2023)

Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol

Knight SR. et al, (2022), Thorax, 77, 606 - 615

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study.

Närhi F. et al, (2022), The Lancet. Digital health, 4, e220 - e234

Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

Leclerc QJ. et al, (2021), BMC Health Services Research, 21

Cookies on this website

All Publications